Efficacy and safety evaluation of CLARITY II laser in treatment of cutaneous vascular lesions

Not Applicable

Completed

• Conditions: Diseases of the skin and subcutaneous tissue

• Registration Number: KCT0007085
• Lead Sponsor: Yonsei University Health System, Severance Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2022-12-30
• Last Update Posted: 6 March 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

1) Adults aged 19-65
2) Individuals with cutaneous vascular lesions (flushing, rosacea)
3) Individuals who understands the purpose and methods of this trial
4) Individuals who can regularly visit our hospital
5) Individuals who agrees to avoid any other dermatologic therapies other than our treatment material

Exclusion Criteria

1) Whom denies to participate
2) Whom allergic to topical anesthesia (lidocaine)
3) Pregnant women, breast feeding women
4) Subjects judged to be unsuitable by the person in charge of the clinical trial for the following conditions
?In case of infectious or inflammatory skin disease at the treatment site
?In case of pigmented skin diseases such as spots at the treatment site
?In case of keloid or collagen or elastic fiber disease
?In case of chronic wasting disease (asthma, diabetes, etc.)
? Risk of bleeding by taking an anticoagulant
?In case of an autoimmune disease
?Person with psychiatric problems
?Person with acute illness
5) Other cases when it is difficult to conduct the clinical (ex. illiteracy, foreigners)

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
5-point scale Global Aesthetic Improvement Scale (GAIS) evaluated based on clinical photos

Secondary Outcome Measures

Name	Time	Method
Mark-vu, Mexameter, subjective improvement graded by participants